Fulgent Accounts Payable from 2010 to 2024
FLGT Stock | USD 18.33 0.46 2.57% |
Accounts Payable | First Reported 2015-12-31 | Previous Quarter 19.9 M | Current Value 19.8 M | Quarterly Volatility 10.2 M |
Check Fulgent Genetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Fulgent Genetics' main balance sheet or income statement drivers, such as Discontinued Operations of 49.5 K, Depreciation And Amortization of 27.5 M or Interest Expense of 38.9 M, as well as many indicators such as Price To Sales Ratio of 2.83, Dividend Yield of 0.018 or PTB Ratio of 0.72. Fulgent financial statements analysis is a perfect complement when working with Fulgent Genetics Valuation or Volatility modules.
Fulgent | Accounts Payable |
Latest Fulgent Genetics' Accounts Payable Growth Pattern
Below is the plot of the Accounts Payable of Fulgent Genetics over the last few years. An accounting item on the balance sheet that represents Fulgent Genetics obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Fulgent Genetics are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. It is the amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities. Fulgent Genetics' Accounts Payable historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Fulgent Genetics' overall financial position and show how it may be relating to other accounts over time.
Accounts Payable | 10 Years Trend |
|
Accounts Payable |
Timeline |
Fulgent Accounts Payable Regression Statistics
Arithmetic Mean | 6,974,322 | |
Geometric Mean | 1,575,004 | |
Coefficient Of Variation | 137.30 | |
Mean Deviation | 8,115,363 | |
Median | 1,581,000 | |
Standard Deviation | 9,575,871 | |
Sample Variance | 91.7T | |
Range | 26.3M | |
R-Value | 0.73 | |
Mean Square Error | 46T | |
R-Squared | 0.53 | |
Significance | 0 | |
Slope | 1,564,799 | |
Total Sum of Squares | 1283.8T |
Fulgent Accounts Payable History
About Fulgent Genetics Financial Statements
Fulgent Genetics shareholders use historical fundamental indicators, such as Accounts Payable, to determine how well the company is positioned to perform in the future. Although Fulgent Genetics investors may analyze each financial statement separately, they are all interrelated. The changes in Fulgent Genetics' assets and liabilities, for example, are also reflected in the revenues and expenses on on Fulgent Genetics' income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
Last Reported | Projected for Next Year | ||
Accounts Payable | 15.4 M | 10.3 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Fulgent Stock Analysis
When running Fulgent Genetics' price analysis, check to measure Fulgent Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fulgent Genetics is operating at the current time. Most of Fulgent Genetics' value examination focuses on studying past and present price action to predict the probability of Fulgent Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fulgent Genetics' price. Additionally, you may evaluate how the addition of Fulgent Genetics to your portfolios can decrease your overall portfolio volatility.